Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3: a systematic analysis of expert opinion
- Tombal, Bertrand
- Ameye, Filip
- de la Taille, Alexandre
- de Reijke, Theo
- Gontero, Paolo
- Haese, Alexander
- Kil, Paul
- Perrin, Paul
- Remzi, Mesut
- Schröder, Jörg
- Speakman, Mark
- Volpe, Alessandro
- Meesen, Bianca
- Stoevelaar, Herman
Publication date
January 2012
DOI Publisher
Springer Science and Business Media LLCAbstract
The Prostate CAncer gene 3 (PCA3) assay may guide prostate biopsy decisions and predict prostate cancer (PCa) aggressiveness. This study explored the appropriateness of (1) PCA3 testing; (2) biopsy; (3) active surveillance (AS) and the value of the PCA3 Score for biopsy and AS decisions
Add to ORKG